Private EquityRIA · CRD 173859SEC-RegisteredPrivate Fund Adviser

Updated:

Revelstoke Capital Partners

Revelstoke Capital Partners is an SEC-registered investment adviser in Denver, CO, registered since 2015. The firm manages approximately $6.7 billion in...

Revelstoke Capital Partners logo

Revelstoke Capital Partners

Revelstoke Capital Partners is an SEC-registered investment adviser in Denver, CO, registered since 2015. The firm manages approximately $6.7 billion in regulatory assets. It has 52 employees and 47 investment advisers.

General information

Firm type

Private Equity

Year founded

2013

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Denver

Corporate office

260 North Josephine Street, Suite 500, Denver, Colorado 80206, United States

Principals

Simon Bachleda

Founder & Managing Partner

Russell Cassella

Managing Partner

Blake Bennett

Partner, Chief Financial Officer & Chief Compliance Officer

Samantha Gordon Webb

Partner, Head of Portfolio Transformation Group

Greg Pupo

Partner, Investor Relations

Sector focus

Healthcare ServicesDigital HealthHealth & Wellness

Frequently asked questions

Who runs investment decisions at Revelstoke?

Founder and Managing Partner Simon Bachleda and Managing Partner Russell Cassella are the firm's most senior investment decision-makers. The team page lists more than 50 professionals including partners, principals, and vice presidents across the investment team and the Portfolio Transformation Group. Day-to-day investment opportunities are directed to Cy Barton-Dobenin at the email listed on the firm's contact page.

Does Revelstoke operate as a single-family office or a private equity firm?

Revelstoke is structured as a private equity firm managing third-party capital. It is not a family office. The firm functions as a traditional fund manager with an investor-relations function led by Partner Greg Pupo, and it has no publicly disclosed ties to a single-family source of capital.

What investment stages does Revelstoke target?

The firm pursues buyout, growth equity, and recapitalization transactions. Its portfolio spans founder-owned, physician-led, and institutionally-backed healthcare businesses. Typical check sizes and fund vintages are not publicly disclosed.

How does Revelstoke add value after an investment?

Revelstoke deploys a dedicated in-house Portfolio Transformation Group led by Partner Samantha Gordon Webb. The group embeds specialists in AI and data science, technology, talent, strategic partnerships, and responsible investment into portfolio companies. This goes beyond the typical operating-partner model to function as a systematized, repeatable value-creation engine across the portfolio.

Which sectors does Revelstoke explicitly avoid?

The firm's publicly stated mandate is limited to healthcare services, healthcare technology, and health and wellness. It does not invest in non-healthcare sectors. Even within healthcare, there is no evidence of exposure to biotech, pharmaceuticals, or medical devices — the portfolio is overwhelmingly service- and technology-delivery businesses.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Denver Private Equity profiles